Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β
Author:
Affiliation:
1. Division of Endocrinology; CSIR-Central Drug Research Institute; Lucknow India
2. Division of Medicinal and Process Chemistry; CSIR-Central Drug Research Institute; Lucknow India
Funder
Ministry of Health and Family Welfare
Publisher
Wiley
Subject
Cancer Research,Molecular Biology
Reference47 articles.
1. Prostate cancer overview. Part 1: Non-metastatic disease;Drudge-Coates;Br J Nurs,2012
2. The complexity of prostate cancer: Genomic alterations and heterogeneity;Boyd;Nat Rev Urol,2012
3. The epigenome as a therapeutic target in prostate cancer;Perry;Nat Rev Urol,2010
4. DNA methylation and cancer;Das;J ClinOncol,2004
5. Epigenetics in cancer;Sharma;Carcinogenesis,2010
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antifungal activity of the repurposed drug disulfiram against Cryptococcus neoformans;Frontiers in Pharmacology;2024-01-11
2. 针灸对子宫内膜异位症大鼠异位内膜组织UHRF1和DNMT1的影响;Journal of Acupuncture and Tuina Science;2023-12-29
3. Disulfiram ameliorates bleomycin induced pulmonary inflammation and fibrosis in rats;Biotechnic & Histochemistry;2023-10-02
4. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway;Cellular Signalling;2023-09
5. Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems;Pharmaceutics;2023-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3